Lansforsakringar Fondforvaltning’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.21M	Buy	250,917 +811	+0.3%	+$13.6K	0.02%	418
2025 Q1	$3.84M	Buy	250,106 +5,344	+2%	+$82.1K	0.02%	435
2024 Q4	$5.39M	Buy	+244,762	New	+$5.39M	0.03%	388